{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:13:16Z","timestamp":1785597196306,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.humpath.2023.06.011","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:59:55Z","timestamp":1687607995000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable"],"prefix":"10.1016","volume":"138","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7610-7769","authenticated-orcid":false,"given":"Hiroshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.06.011_bib1","first-page":"87","article-title":"Global cancer statistic, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2023.06.011_bib2","first-page":"209","article-title":"Global cancer statistic 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2023.06.011_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/bju.14237","article-title":"Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer","volume":"122","author":"Lancee","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2023.06.011_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European Association of Urology prostate cancer guidelines panel recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.humpath.2023.06.011_bib5","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 international society of urological pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.011_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2023.06.011_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0046-8177(98)90423-3","article-title":"Patterns of\u00a0high-grade prostatic intraepithelial neoplasia associated with\u00a0clinically aggressive prostate cancer","volume":"29","author":"Wilcox","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.06.011_bib8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.06.011_bib9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.juro.2010.06.017","article-title":"Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings","volume":"184","author":"Robinson","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2023.06.011_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/JU.0000000000001290","article-title":"The prognostic impact of intraductal carcinoma of the prostate: a systematic review and meta-analysis","volume":"204","author":"Miura","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2023.06.011_bib11","series-title":"Urinary and male genital tumours","first-page":"200","year":"2022"},{"key":"10.1016\/j.humpath.2023.06.011_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5858\/arpa.2021-0346-OA","article-title":"The clinical impact of comedonecrosis within intraductal carcinoma of the prostate","volume":"147","author":"Wang","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2023.06.011_bib13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/PAS.0000000000001104","article-title":"Comedonecrosis revisited: strong association with intraductal carcinoma of the prostate","volume":"42","author":"Fine","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.011_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/his.13833","article-title":"Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria","volume":"74","author":"Madan","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.06.011_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason\u00a0grading of prostatic carcinoma","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.011_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical recurrence following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.humpath.2023.06.011_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software\u00a0\u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.06.011_bib18","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41379-021-00860-4","article-title":"Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients","volume":"34","author":"Hansum","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.06.011_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00428-022-03301-y","article-title":"Alternative prostate cancer grading systems incorporating percent pattern 4\/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy","volume":"480","author":"Seyrek","year":"2022","journal-title":"Virchows Arch"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:42:08Z","timestamp":1758645728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723001429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":19,"alternative-id":["S0046817723001429"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.06.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}